Variant report
Variant | esv3379572 |
---|---|
Chromosome Location | chr6:48526443-48528341 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149939941 | chr6:48526465-48526466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145008715 | chr6:48526523-48526524 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576521744 | chr6:48526545-48526546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540137751 | chr6:48526566-48526567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564497606 | chr6:48526569-48526570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201847008 | chr6:48526590-48526591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532018997 | chr6:48526637-48526638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74952137 | chr6:48526679-48526680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191294315 | chr6:48526680-48526681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73739327 | chr6:48526682-48526683 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs549521540 | chr6:48526724-48526725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9395367 | chr6:48526754-48526755 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs182929181 | chr6:48526827-48526828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547327495 | chr6:48526832-48526833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571661627 | chr6:48526846-48526847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187136624 | chr6:48526925-48526926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144886868 | chr6:48526943-48526944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551006305 | chr6:48526993-48526994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569371289 | chr6:48526997-48526998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571156963 | chr6:48527086-48527087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35827654 | chr6:48527102-48527103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375625015 | chr6:48527118-48527119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191281107 | chr6:48527124-48527125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114336284 | chr6:48527167-48527168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572709123 | chr6:48527201-48527202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116446885 | chr6:48527202-48527203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574755810 | chr6:48527228-48527229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35163598 | chr6:48527233-48527234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572864886 | chr6:48527256-48527257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558468343 | chr6:48527267-48527268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576408443 | chr6:48527294-48527295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571924048 | chr6:48527296-48527297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375982277 | chr6:48527312-48527313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562360988 | chr6:48527373-48527374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529767980 | chr6:48527449-48527450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183772658 | chr6:48527471-48527472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561427669 | chr6:48527479-48527480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187558235 | chr6:48527520-48527521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138179410 | chr6:48527523-48527524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs3010534 | chr6:48527525-48527526 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs73475839 | chr6:48527588-48527589 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs141259990 | chr6:48527621-48527622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559032834 | chr6:48527646-48527647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577555680 | chr6:48527660-48527661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145053677 | chr6:48527673-48527674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs111351772 | chr6:48527676-48527677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554804226 | chr6:48527678-48527679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555453301 | chr6:48527688-48527689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143232650 | chr6:48527710-48527711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs193097764 | chr6:48527732-48527733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:48522000-48527600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr6:48525400-48526600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr6:48526600-48531200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:48527600-48528400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:48527600-48528600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr6:48527800-48528200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr6:48527800-48528600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr6:48527800-48528600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr6:48527800-48528600 | Enhancers | NHEK | skin |
10 | chr6:48528000-48528400 | Enhancers | HMEC | breast |
11 | chr6:48528000-48528600 | Enhancers | HUVEC | blood vessel |
12 | chr6:48528000-48528600 | Enhancers | Osteobl | bone |
13 | chr6:48528200-48531200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |